BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kirchhoff T, Zender L, Merkesdal S, Frericks B, Malek N, Bleck J, Kubicka S, Baus S, Chavan A, Manns MP, Galanski M. Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 2005; 11(8): 1091-1095 [PMID: 15754387 DOI: 10.3748/wjg.v11.i8.1091]
URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1091.htm
Number Citing Articles
1
Chet W. Hammill, Linda L. Wong. Intrahepatic Cholangiocarcinoma: A Malignancy of Increasing ImportanceJournal of the American College of Surgeons 2008; 207(4) doi: 10.1016/j.jamcollsurg.2008.04.031
2
Charles E. Ray, Anthony Edwards, Mitchell T. Smith, Stephen Leong, Kimi Kondo, Matthew Gipson, Paul J. Rochon, Rajan Gupta, Wells Messersmith, Tom Purcell, Janette Durham. Metaanalysis of Survival, Complications, and Imaging Response following Chemotherapy-based Transarterial Therapy in Patients with Unresectable Intrahepatic CholangiocarcinomaJournal of Vascular and Interventional Radiology 2013; 24(8) doi: 10.1016/j.jvir.2013.03.019
3
S. Herber, G. Otto, J. Schneider, N. Manzl, I. Kummer, S. Kanzler, A. Schuchmann, J. Thies, C. Düber, M. Pitton. Transarterial Chemoembolization (TACE) for Inoperable Intrahepatic CholangiocarcinomaCardioVascular and Interventional Radiology 2007; 30(6) doi: 10.1007/s00270-007-9032-7
4
M. Knüppel, S. Kubicka, A. Vogel, N. P. Malek, M. Schneider, F. Papendorf, T. Greten, J. Wedemeyer, A. Schneider. Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival AnalysisGastroenterology Research and Practice 2012; 2012 doi: 10.1155/2012/190708
5
Satoru Seo, Etsuro Hatano, Tatsuya Higashi, Akio Nakajima, Yuji Nakamoto, Masaharu Tada, Nobuyuki Tamaki, Keiko Iwaisako, Akira Mori, Ryuichiro Doi, Iwao Ikai, Shinji Uemoto. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinomaSurgery 2008; 143(6) doi: 10.1016/j.surg.2008.01.010
6
Kerri A. Simo, Laura E. Halpin, Nicole M. McBrier, Jacob A. Hessey, Erin Baker, Samuel Ross, Ryan Z. Swan, David A. Iannitti, John B. Martinie. Multimodality treatment of intrahepatic cholangiocarcinoma: A reviewJournal of Surgical Oncology 2016; 113(1) doi: 10.1002/jso.24093
7
Melanie B. Thomas. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapyCritical Reviews in Oncology/Hematology 2007; 61(1) doi: 10.1016/j.critrevonc.2006.07.006
8
Tomáš Andrašina, Vlastimil Válek, Jiří Pánek, Zdeněk Kala, Igor Kiss, Štěpán Tuček, Pavel Šlampa. Multimodal Oncological Therapy Comprising Stents, Brachytherapy, and Regional Chemotherapy for CholangiocarcinomaGut and Liver 2010; 4(Suppl.1) doi: 10.5009/gnl.2010.4.S1.S82
9
Hiroto Ota, Hiroaki Nagamatsu, Ko Tomishima, Shigeto Ishii, Toshio Fujisawa, Yusuke Takasaki, Daisuke Namima, Sho Takahashi, Taito Fukuma, Daishi Kabemura, Muneo Ikemura, Ippei Ikoma, Yasuhisa Jimbo, Maki Tobari, Hitoshi Maruyama, Hiroyuki Isayama. Efficacy of New Hepatic Arterial Infusion Chemotherapy with Lipiodol, a New-FP Therapy for Unresectable Advanced Intrahepatic Cholangiocarcinoma (iCCA)Internal Medicine 2026;  doi: 10.2169/internalmedicine.7025-25
10
Danish Mazhar, Justin Stebbing, Mark Bower. Chemotherapy For Advanced Cholangiocarcinoma: What Is Standard Treatment?Future Oncology 2006; 2(4) doi: 10.2217/14796694.2.4.509
11
Pankaj Singh, Tushar Patel. Advances in the diagnosis, evaluation and management of cholangiocarcinomaCurrent Opinion in Gastroenterology 2006; 22(3) doi: 10.1097/01.mog.0000218967.60633.64
12
Kelvin Hong, Jean-Francois H. Geschwind. Locoregional Intra-arterial Therapies for Unresectable Intrahepatic CholangiocarcinomaSeminars in Oncology 2010; 37(2) doi: 10.1053/j.seminoncol.2010.03.002
13
Yucel Ustundag, Yusuf Bayraktar. Cholangiocarcinoma: A compact review of the literatureWorld Journal of Gastroenterology 2008; 14(42): 6458-6466 doi: 10.3748/wjg.14.6458
14
Peter Huppert, Nikolas Kortes, Clemens Kratochwil, Boris Radeleff, Anne Schmitz, Ulrike Stampfl. Angiofibel2021;  doi: 10.1007/978-3-662-56243-7_14
15
Matthew V. Kiefer, Marissa Albert, Madeline McNally, Mary Robertson, Weijing Sun, Douglas Fraker, Kim Olthoff, Kathleen Christians, Sam Pappas, William Rilling, Michael C. Soulen. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholCancer 2011; 117(7) doi: 10.1002/cncr.25625
16
Alfredo Guglielmi, Andrea Ruzzenente, Calogero Iacono. Surgical Treatment of Hilar and Intrahepatic CholangiocarcinomaUpdates in Surgery 2008;  doi: 10.1007/978-88-470-0729-1_23
17
Thomas J. Ettrich, Thomas Seufferlein. Locoregional Tumor Therapy2018;  doi: 10.1007/978-3-319-69947-9_5
18
Sebastian Mondaca, Hooman Yarmohammadi, Nancy E. Kemeny. Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular CarcinomaSurgical Oncology Clinics of North America 2019; 28(4) doi: 10.1016/j.soc.2019.06.008
19
C. Margarit, A. Escartín, J. Bellmunt, E. Allende, I. Bilbao. Colangiocarcinoma periférico: resultados del tratamiento quirúrgicoGastroenterología y Hepatología 2006; 29(4) doi: 10.1157/13085990
20
Niraj J. Gusani, Fady K. Balaa, Jennifer L. Steel, David A. Geller, J. Wallis Marsh, Albert B. Zajko, Brian I. Carr, T. Clark Gamblin. Treatment of Unresectable Cholangiocarcinoma with Gemcitabine-Based Transcatheter Arterial Chemoembolization (TACE): A Single-Institution ExperienceJournal of Gastrointestinal Surgery 2008; 12(1) doi: 10.1007/s11605-007-0312-y
21
Lara Maria Pasetto, Mario Rosario D’Andrea, Cristina Falci, Silvio Monfardini. Gemcitabine in advanced biliary tract cancersCritical Reviews in Oncology/Hematology 2007; 61(3) doi: 10.1016/j.critrevonc.2006.04.006
22
Fabian Goerg, Markus Zimmermann, Philipp Bruners, Ulf Neumann, Tom Luedde, Christiane Kuhl. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot StudyCardioVascular and Interventional Radiology 2019; 42(12) doi: 10.1007/s00270-019-02344-0
23
Eun-Young Kim, Sang Soo Lee, Ji Hoon Shin, Soo Hyun Kim, Dong-Ho Shin, Seung Yon Baek. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse modelClinical and Experimental Medicine 2014; 14(2) doi: 10.1007/s10238-013-0233-x
24
Thomas Ettrich, Thomas Seufferlein. Locoregional Tumor Therapy2015;  doi: 10.1007/978-3-642-36572-0_6
25
Guo Wei, Ming-Ming Nie, Xiao-Jun Shen, Xu-Chao Xue, Li-Ye Ma, Cheng-Hui Du, Shi-Liang Wang, Jian-Wei Bi. Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic AbdominalisAsian Pacific Journal of Cancer Prevention 2014; 15(1) doi: 10.7314/APJCP.2014.15.1.407
26
Thomas J. Vogl, Nagy N.N. Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment successInternational Journal of Cancer 2012; 131(3) doi: 10.1002/ijc.26407
27
Ron C. Gaba, R. Peter Lokken, Ryan M. Hickey, Andrew J. Lipnik, Robert J. Lewandowski, Riad Salem, Daniel B. Brown, T. Gregory Walker, James E. Silberzweig, Mark Otto Baerlocher, Ana Maria Echenique, Mehran Midia, Jason W. Mitchell, Siddharth A. Padia, Suvranu Ganguli, Thomas J. Ward, Jeffrey L. Weinstein, Boris Nikolic, Sean R. Dariushnia. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic MalignancyJournal of Vascular and Interventional Radiology 2017; 28(9) doi: 10.1016/j.jvir.2017.04.025
28
Jan B. Kuhlmann, Wulf Euringer, Hans C. Spangenberg, Matthias Breidert, Hubert E. Blum, Jan Harder, Richard Fischer. Treatment of unresectable cholangiocarcinomaEuropean Journal of Gastroenterology & Hepatology 2012;  doi: 10.1097/MEG.0b013e3283502241